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ABSTRACT
Mechanisms responsible for the lack of thyroid-specific differen-
tiation markers in Ha-ras transformed FRTL-5 cells have been in-
vestigated. In vivo cell labeling and immunoprecipitation demon-
strate that phosphorylation of the thyroid transcription factor-1
(TTF-1) is clearly reduced in thyroid cells transformed with the Ha-
ras oncogene. Fingerprinting analysis of phosphotryptic peptides
from FRTL-5 and Ha-ras-FRTL-5 cells also reveals a heterogeneous
pattern of TTF-1 phosphorylation in the transformed cell line. This
heterogeneity is localized in the amino terminal cluster of phospho-
serines, as determined by transfection of HeLa cells with TTF-1 mu-
tants in which serine residues have been replaced by alanines. Am-
plification and nucleotide sequence of the 59-coding region of the
TTF-1 gene in Ha-ras-FRTL-5 cells rule out the possibility that dif-
ferences in phosphorylation were the consequence of any mutational
event affecting residues within the N-terminal protein sequence. Hy-
pophosphorylated TTF-1 is still able to bind its DNA consensus se-
quence within the thyroglobulin promoter, although a reporter con-
struct whose expression is exclusively dependent on TTF-1 is not
transactivated. Transfection of Ha-ras-FRTL-5 cells with an expres-
sion vector encoding the cAMP dependent protein kinase A (PKA)
catalytic subunit partially reestablishes TTF-1 transcriptional activ-
ity. Taken together, these results indicate that the lack of specific
thyroid gene expression in Ha-ras-FRTL-5 cells could be a direct
consequence of the inability of TTF-1 to promote transcription. (En-
docrinology 139: 2796–2802, 1998)
THYROID-DIFFERENTIATED phenotype is defined bythe expression of specific genes, thyroglobulin (Tg),
thyroperoxidase (TPO), TSH receptor (TSH-R), and the
Na1/I2 symporter (NIS) for iodide trapping (1, 2). So far,
three tissue-specific transcription factors have been isolated:
thyroid transcription factor (TTF) 1 and 2, homeo- and fork-
head domain-containing proteins, and the paired-box factor
Pax-8 (3–5). Binding sites for TTF-1 have been identified and
functionally characterized within the Tg, TPO, and TSH-R
gene promoters (6–9) and also recently in the rat NIS pro-
moter (10, 11), attributing to TTF-1 a main role in the main-
tenance of the thyroid differentiated phenotype.
Loss of differentiation as a result of cellular transformation
is a well characterized phenomenon (12). In many thyroid
tumors, expression of molecular markers such as Tg and TPO
and their corresponding transcription factors TTF-1 and
Pax-8 is lost, particularly in late stages of thyroid carcino-
genesis (13). Oncogenic transformation of thyroid cells in
culture mimics this loss of differentiation, and experiments
with FRTL-5 thyroid cells demonstrate that Ha- and Ki-ras
transformation also abolish Tg and TPO expression com-
pletely. However, while in Ki-ras transformed cells TTF-1 is
undetectable, Ha-ras-FRTL-5 cells display normal levels of
TTF-1 messenger RNA (mRNA) and protein (14).
Previous results from our laboratory showed that TTF-1,
encoded by the titf-1 locus, is a phosphoprotein required for
specific expression of Tg and TPO (15). Precise mapping of
the TTF-1 phosphorylation sites demonstrated that this tran-
scription factor is phosphorylated on a maximun of seven
serine residues distributed in three different phosphotryptic
peptides (15). Therefore, as described for many other tran-
scription factors, phosphorylation appears to be a key reg-
ulatory mechanism by which TTF-1/DNA binding and/or
transactivation could be modulated. Several observations
indicate that phosphorylation of TTF-1 may be relevant only
in specific cell types. Previous works in thyroid cells pro-
posed that phosphorylation is a critical step for TTF-1 bind-
ing to the Tg promoter (16), whereas studies in TTF-1-trans-
fected HeLa cells indicated that phosphorylation does not
play an important role in the regulation of TTF-1 DNA bind-
ing activity (15). Therefore, the biological significance of
TTF-1 phosphorylation remains to be elucidated.
In this study, we have searched for regulatory mechanisms
affecting TTF-1 activity that could be altered upon Ha-ras
transformation. Using a construct containing a specific TTF-1
responsive element within the Tg promoter (17), we dem-
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onstrate that the ability of TTF-1 to promote transcription is
lost in cells transformed with the Ha-ras oncogene. This
ability is partially reestablished when the catalytic subunit of
the protein kinase A (PKA) is expressed in these cells. In vivo
cell labeling and immunoprecipitation of TTF-1 from Ha-
ras-FRTL-5 cells show a clear decrease in the overall extent
of phosphorylation, along with a heterogeneity in the dis-
tribution of the phosphorylated serines. This heterogeneous
phosphorylation is more prominent within the amino ter-
minal region of the protein.
Materials and Methods
Cell culture
FRTL-5 thyroid cells (18) (ATCC CRL 8305; American Type Culture
Collection, Rockville, MD) were grown in Coon’s modified Ham’s F-12
medium (Sigma Chemical Co., St. Louis, MO) supplemented with 5%
donor calf serum (GIBCO, Life Technologies, Inc., Gaithersburg, MD)
and a hormone mixture including 0.5 mU/ml TSH and 10 mg/ml insulin
(Sigma). Ha-ras transformed FRTL-5 cells (19) were maintained in the
same conditions. HeLa cells were grown in DMEM supplemented with
10% FCS (Gibco Life Technologies).
TTF-1 protein analysis
FRTL-5 or transformed Ha-ras-FRTL-5 cells were labeled in methi-
onine-free medium containing 0.5 mCi of [35S] methionine/ml for 2 h.
Cells were lysed in a buffer containing 10 mm sodium phosphate (pH
7.4), 0.1 m NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate,
2 mm phenylmethylsulfonil fluoride, 1 mg/ml pestatin, 1 mg/ml leu-
peptin, 1 mg/ml aprotinin, 50 mm sodium fluoride, 10 mm sodium
pyrophosphate, and 5 mm sodium vanadate. Extracts were incubated
with an specific TTF-1 antibody (15) coupled to protein A sepharose
beads (Pharmacia Biotech Inc., Piscataway, NJ). Immune complexes
were washed extensively with lysis buffer, boiled in SDS-Laemmli sam-
ple buffer, and resolved by SDS 8%-PAGE. For Western blot, nuclear
extracts were obtained as described (20) and subjected to SDS-PAGE.
Proteins were then transferred to nitrocellulose membranes and probed
with the same TTF-1 specific antibody (15). After incubation with a sec-
ondary antibody, immunoreactive bands were visualized by enhanced
chemiluminescence ECL (Amersham Corp., Arlington Heights, IL).
Electrophoretic mobility shift assays
DNA binding assays were performed as described (21) using 32P-
labeled double-stranded oligonucleotide C (59-CACTGCCCAGT-
CAAGTGTTCTTGA-39) derived from the 292 to 268 region of the Tg
promoter and shown to recognize the transcription factor TTF-1 (6).
Nuclear proteins (3 mg), prepared as described (20), were preincubated
15 min on ice in a binding reaction mixture containing 40 mm HEPES,
pH 7.9, 200 mm KCl, 0.5 mm DTT, 0.2 mm EDTA, 5% Ficoll, and 3 mg
poly(dI-dC). In competition and supershift experiments, 100-fold excess
of unlabeled competitor or 1 mg of TTF-1 antibody were added, respec-
tively. Then 50 pg of labeled C probe were added to the mixture and
incubated for 30 min at room temperature. The resulting DNA-protein
complexes were separated from free DNA on a 5% polyacrilamide gel.
Plasmids and transfections
For detection of TTF-1 transcriptional activity, the constructs C5E1b-
CAT and E1b (17), referred in this work as 5C-CAT and TATA-CAT,
respectively, were transiently transfected by the calcium phosphate pre-
cipitation technique (22) into FRTL-5 and Ha-ras-FRTL-5 cells. The 5C-
CAT construct contains five tandem repeats of the C binding site from
the Tg promoter, and it is exclusively dependent on TTF-1 for transac-
tivation (17). TATA-CAT was used as a negative control. The plasmid
CMV-Luc (17) was used to correct for transfection efficiency. Forty eight
hours after transfection, cell extracts were prepared and CAT (22) and
luciferase activities (23) determined. For PKA overexpression assays,
vectors containing either a wild-type or a mutated PKA catalytic subunit
(24) were transfected in Ha-ras-FRTL-5 cells. TTF-1 mutants carrying
Ser/Ala substitution were generated by PCR as previously described
(15). Expression vectors for wild-type and mutant TTF-1 complementary
DNAs were transfected into HeLa cells 36 h before in vivo labeling.
In vivo labeling and fingerprinting analysis of
phosphopeptides
Exponentially growing FRTL-5, their Ha-ras derivatives and trans-
fected HeLa cells were maintained in phosphate-free medium for 30 min,
then labeled with 0.5 mCi of [32P] orthophosphate/ml for 3 h. Cell
extracts and TTF-1 immunoprecipitation were performed as described
above. Immunoprecipitated, in vivo phosphorylated TTF-1 and the dif-
ferent mutant proteins were separated in SDS 8% polyacrilamide gel
electrophoresis and electroblotted to nitrocellulose. After autoradiog-
raphy of the membranes, the bands were excised and digested with
trypsin-TPCK (Worthington) as described (15). The resulting solubilized
peptides were collected, oxidized, and loaded onto TLC plates (25). First
dimension separation was performed by electrophoresis at 1,000 V in
0.13 m (NH4)2CO3, pH 8.9, for 30 min. TLC plates were then subjected
to chromatography in isobutiric: pyridine: acetic acid: n-butanol:water
(62.5: 4.8: 2.9: 1.9: 27.9). When necessary, phosphopeptides were recov-
ered from the TLC plate and subjected to chemical cleavage with cy-
anogen bromide (CNBr) in the conditions described (26).
TTF-1 mutational analysis
A 200-bp DNA fragment containing the N-terminal region of the
TTF-1 protein was amplified from FRTL-5 and Ha-ras-FRTL-5 genomic
DNA by PCR, using the primers 59-AGTAGCGAGGCTTCGCCTTC-39
and 59-TGTCTGTAAGCTGCGAGCGG-39 for forward and reverse an-
nealing, respectively. Amplification was performed following standard
protocols using Taq polymerase (Perkin Elmer Co., Foster City, CA).
Amplified DNA fragments were subcloned in the pCRII vector (Invitro-
gen, Carlsbad, CA), and a representative number of positive clones were
sequenced (Applied Biosystems, Foster City, CA). Sequences were
aligned using the Pileup program (GCG package, University of Wis-
consin DNA software) and compared with the previously published
TTF-1 sequence (27).
Results
TTF-1 phosphorylation is clearly reduced in Ha-ras
transformed FRTL-5 cells
The presence of detectable TTF-1 mRNA and protein, to-
gether with the lack of thyroid-specific genes Tg and TPO in
Ha-ras-FRTL-5 cells (14), prompted us to analyze posttran-
scriptional mechanisms affecting TTF-1 function in this
transformed cell line. We focused our attention in potential
changes in TTF-1 phosphorylation.
The levels of TTF-1 phosphorylation in thyroid FRTL-5
cells and their Ha-ras transformed counterpart were ana-
lyzed by in vivo 32P labeling and immunoprecipitation. Equal
number of exponentially growing cells were incubated with
radiolabeled orthophosphate. After protein extraction, im-
munoprecipitated TTF-1 was separated by electrophoresis
(Fig. 1A). A marked decrease in TTF-1 phosphorylation was
observed in Ha-ras transformed FRTL-5 cells, as determined
by the amount of 32P incorporated into the transcription
factor. Comparison with the parental FRTL-5 cells and quan-
titation of the signal by densitometric scanning indicated up
to a 5-fold reduction in the amount of radiolabeled 32P in
TTF-1 immunoprecipitated from Ha-ras-FRTL-5 cells. We
ruled out the possibility that differences in radioactive la-
beling were due to the presence of different amount of TTF-1
protein in both extract preparations. For that purpose,
steady-state levels and de novo protein synthesis were deter-
mined by Western blot and immunoprecipitation of 35S-me-
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thionine-labeled TTF-1 (Fig. 1B), respectively. In both cases,
comparable levels of immunoreactive TTF-1 signal was ob-
served, unambiguously indicating that differences in 32P la-
beling were exclusively due to a decrease in the amount of
tracer incorporation.
TTF-1 retains DNA binding capacity, although it is unable
to promote gene transcription in Ha-ras-FRTL-5 cells
We then analyzed whether the TTF-1 protein in Ha-ras-
FRTL-5 exhibits any alteration in either DNA binding ca-
pacity or transactivation activity. Figure 2A shows the results
of the electrophoretic mobility shift assay performed to de-
tect the presence of protein-DNA complexes in crude nuclear
extracts from FRTL-5 and Ha-ras-FRTL-5 cells. Incubation of
equal amounts of nuclear proteins with a 32P-labeled C oli-
gonucleotide and separation by nondenaturing polyacryl-
amide gel electrophoresis yielded the same TTF-1/DNA
complexes in both cell types (lanes 2 and 3). Specificity of the
complex in Ha-ras-FRTL-5 was assayed using a 100-fold ex-
cess of an unrelated oligonucleotide (lane 4) or unlabeled oli-
gonucleotide C (lane 5). The identity of the complex in FRTL-5
and Ha-ras-FRTL-5 was further confirmed by supershift assays
using an anti-TTF-1 specific antibody (lanes 6 and 7).
From the above experiments we concluded that the low
levels of TTF-1 phosphorylation observed in Ha-ras-FRTL-5
do not modify the capacity of the transcription factor to bind
its DNA recognition sequence. Therefore, we analyzed the
ability of TTF-1 to promote transcription in transformed and
nontransformed thyroid cells, using a construct exclusively
dependent on TTF-1 for transactivation. This construct, con-
taining five tandem repeats of the oligonucleotide C, or a
minimal promoter TATA-CAT control vector (17), were tran-
siently transfected in both FRTL-5 and Ha-ras-FRTL-5 cells.
The activity was determined assaying crude cell extracts for
CAT activity, whereas luciferase activity derived from the
CMV-Luc plasmid was used to correct variability in trans-
fection efficiencies. Consistent with a functional TTF-1 pro-
tein in normal cells, activity of the 5C-CAT construct in
FRTL-5 was clearly observed (Fig. 2B). However, when this
construct was transfected in Ha-ras-FRTL-5 cells, CAT ac-
tivity values were comparable with those obtained in the
negative control, indicating that TTF-1 is unable to promote
transcription in Ha-ras-transformed FRTL-5 cells.
FIG. 1. Phosphorylation of TTF-1 in FRTL-5 and Ha-ras-FRTL-5
cells. A, The same number of thyroid FRTL-5 and Ha-ras transformed
FRTL-5 cells were in vivo labeled with 32P before TTF-1 immuno-
precipitation. Proteins were resolved in a SDS-8% PAGE and detected
by autoradiography. B, In the same experimental conditions, TTF-1
was immunoprecipitated from 35S methionine-labeled cell cultures
(upper panel), or immunodetected by Western blot (lower panel).
FIG. 2. Binding and transcriptional ac-
tivity of TTF-1 in FRTL-5 and Ha-ras-
FRTL-5 cells. A, TTF-1 binding to oli-
gonucleotide C was assayed as
described in Materials and Methods.
Nuclear extracts were prepared from
FRTL-5 or Ha-ras transformed FRTL-5
cells (lane 2 and 3). The specificity of the
retarded complex was established by
competition with a 100-fold excess of an
unrelated oligonucleotide (lane 4) or un-
labeled oligonucleotide C (lane 5). The
identity of the complex was demon-
strated by supershift with an anti-
TTF-1 antibody (lanes 6 and 7). B, Ten
micrograms of the construct containing
five tandem repeats of the TTF-1 bind-
ing site (5C-CAT) and the promoterless
vector TATA-CAT were transiently
transfected in FRTL-5 and Ha-ras-
FRTL-5 cells. CAT activity was normal-
ized for transfection efficiency and ex-
pressed relative to the activity of the
5C-CAT construct (100%) in control
FRTL-5 cells. The data are from three
independent experiments.
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Changes in TTF-1 phosphorylation pattern in Ha-ras
transformed FRTL-5 cells
The results described above provide a direct correlation
between the absence of the thyroid differentiation marker Tg
and the inability of TTF-1 to promote transcription in Ha-
ras-FRTL-5 cells. The fact that this functional alteration is
associated with a decrease in 32P-radiolabeled TTF-1 in these
transformed cells prompted us to analyze alterations of
TTF-1 phosphorylation in more detail. We investigated
whether the reduction of phosphorylation either targets to
any particular serine residue/s or affects the overall phos-
phorylation extent of the TTF-1 molecule. To address this
question, cultures from FRTL-5 and Ha-ras-FRTL-5 cells
were in vivo labeled with 32P-orthophosphate. Immunopre-
cipitated TTF-1 was separated by electrophoresis and trans-
ferred to nitrocellulose. Membrane-bound TTF-1 was di-
gested with tripsin-TPCK and resulting peptides were
resolved by two dimensional electrophoresis-chromatogra-
phy, as described in Materials and Methods. Representative
experiments, where the same number of counts were loaded,
are shown in Fig. 3. TTF-1 fingerprinting analysis from
FRTL-5 cells shown the migration of three phosphotryptic
peptides (designated 1, 2, and 3), consistent with the previ-
ously described phosphorylation pattern (15). Analysis from
Ha-ras transformed cells revealed a similar pattern with tryp-
tic phosphopeptides 1 and 2 migrating at the bottom of the
TLC place. However, a heterogeneous mobility of phos-
phopeptide 3 was observed. This peptide, clearly defined in
FRTL-5 cells, migrates as a doublet in the transformed cell
line, and two phosphopeptides were identified (3a and 3b).
Mixing experiments of both preparations indicated that spot
3 of FRTL-5 cells corresponds to spot 3a in Ha-ras-FRTL-5
cells (not shown), and, therefore, 3a and 3b are different
phosphorylation stages of the same peptide. The faster mo-
bility of peptide 3b indicates a higher amount of 32P incor-
poration into this phosphopeptide.
Alteration of TTF-1 phosphorylation in Ha-ras-FRTL-5 cells
affects the N-terminal cluster of phosphoserines
To localize tryptic peptide 3 within the TTF-1 protein,
HeLa cells were initially transfected with either wild-type or
different serine phosphorylation mutants and then labeled
with 32P-orthophosphate. We reasoned that this approach, in
which specific phosphorylation sites are artificially removed
from the TTF-1 protein sequence (15), would allow us to
determine the relative position of the phosphopeptides in the
TTF-1 protein, by comparison of the tryptic maps. After
immunoprecipitation and digestion of the TTF-1 protein,
phosphopeptides were resolved by fingerprinting analysis
(Fig. 4). As for the endogenous TTF-1, three major phos-
phopeptides were identified in HeLa cells transfected with
wild-type TTF-1 (panel A). Construct S1–24, bearing four
alanines replacing serines in the N-terminal region produced
a peptide map in which peptide 3 completely disappeared
(panel B). Tryptic map of 32P labeled S64 mutant where the
two serines in the C-terminal has been replaced with alanines
shows peptide 3 migration at the upper right corner of the
chromatography plate, whereas peptide 1 is missing at the
bottom. Double mutant S61 (panel C) indicates that peptide
2 derives from the TTF-1 central region, and confirms the
identity of peptide 3 with the N-terminal.
Once peptide 3 was localized in the parental cell line, we
FIG. 3. Heterogeneity of TTF-1 phosphorylation in Ha-ras-FRTL-5
cells. 32P-labeled-TTF-1 was immunoprecipitated from FRTL-5 cells
and Ha-ras-FRTL-5 cells, subjected to SDS-PAGE, and transferred to
nitrocellulose. Membrane-bound TTF-1 was digested with trypsin
and resulting phosphopeptides resolved by two dimensional electro-
phoresis-chromatography. Representative autoradiographs are
shown. The position of sample application are indicated at the bottom
of the autoradiographs.
FIG. 4. Identification of tryptic phosphopeptides within the TTF-1
protein. HeLa cells were transfected with a wild-type TTF-1 expres-
sion vector (A) or constructs carrying Ser/Ala substitutions in differ-
ent positions (B–D). After transfection, cell cultures were labeled with
32P and TTF-1 immunoprecipitated for phosphotryptic peptide map-
ping. Position of phosphoserines (z) are indicated within the TTF-1
schemes. Ser/Ala substitutions in the different mutant constructs
(S1–24, S61 and S64) are also indicated (X). The homeodomain of the
TTF-1 protein sequence is boxed.
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confirmed the observation that peptides 3a and 3b found in
Ha-ras-FRTL-5 cells correspond to different phophorylation
stages of the same peptide. After analyzing the amino acid
sequence of the N-terminal in detail, we chose a chemical
cleavage with CNBr (26), which would digest peptide 3 at
amino acid positions Met3-Ser4 and Met29-Glu30, leaving the
four phosphoserines in one unique subpeptide, whose mi-
gration could be easily and precisely compared by one di-
mension chromatography. Peptides corresponding with
spots 3, 3a, and 3b were recovered from the TLC plate and
digested with CNBr. Samples were then separated on a new
TLC plate and migration compared. Under these conditions,
the three reactions yielded a unique radiolabeled peptide
(designated CN-3) showing equal mobility (Fig. 5B). These
results allowed us to conclude that the three radiolabeled
peptides correspond to the same TTF-1 protein fragment and
also demonstrated that no other residue is phosphorylated in
peptide 3 in Ha-ras-FRTL-5 cells.
We considered the possibility that differences in phos-
phorylation detected in the peptides maps could be attrib-
utable to the presence of an specific mutation affecting the
amino acid sequence of the N-terminal region of TTF-1. To
test this possibility, we used a PCR approach with specific
primers designed from the previously published TTF-1 se-
quence (27). A unique 200 bp PCR product, containing cod-
ing sequence from amino acid 1 to 25, was amplified from
FRTL-5 and Ha-ras-FRTL-5 genomic DNA. These PCR prod-
ucts were subcloned and sequenced. The translation of the
DNA sequence obtained from Ha-ras-FRTL-5 is shown (Fig.
5A) and corresponds to that obtained in FRTL-5 cells and to
the previously published TTF-1 gene (27). These results ruled
out the possibility that differences in phosphorylation could
be the consequence of mutations affecting residues at the
N-terminal TTF-1 region, supporting the notion that as a
consequence of the Ha-ras transformation, specific kinase
pathways are altered and lead to modifications of TTF-1
phosphorylation.
PKA overexpression partially reestablishes TTF-1
transcriptional activity in Ha-ras-FRTL-5 cells
To gain further insights in the mechanisms responsible for
the differential phosphorylation of TTF-1 in Ha-ras-FRTL-5
cells, we explored the participation of signal transduction
pathways that could be involved in the regulation of TTF-1
transcriptional activity. Because previous works have cor-
related Ha-ras transformation with alteration of different
kinase pathways (28) and considering a recent report de-
scribing and characterizing a functional PKA phosphoryla-
tion site within the N-terminal motif of TTF-1 (29), we an-
alyzed whether exogenous expression of PKA in Ha-ras-
FRTL-5 cells modulates transcriptional activity of TTF-1. Ha-
ras-FRTL-5 cells were cotransfected with different
concentrations (0.5, 1, 2, 4, and 6 mg) of an expression vector
containing either the wild-type or the mutated PKA catalytic
subunit (24), along with the 5C-CAT or the TATA-CAT con-
structs. CAT and luciferase activities were determined in cell
extracts (Fig.6). Overexpression of PKA in Ha-ras-FRTL-5
cells yielded a moderate increase (2-fold) in 5C-CAT activity,
whereas no increase was found with the TATA-CAT con-
struct. The maximum activity was obtained when 2 mg of the
wild-type PKA vector was cotransfected, whereas no in-
crease in CAT activity was found when the mutated PKA
was used. These data indicate that PKA is able to partially
reestablish transcriptional activity of TTF-1. Nevertheless,
CAT activity values in Ha-ras-FRTL-5 cells in the presence of
PKA were significantly lower than those obtained in normal
FRTL-5 (Fig. 2B), indicating that other kinase pathways, pre-
FIG. 5. Sequence analysis and chemical cleavage of the N-terminal
region of TTF-1. A, Nucleotide sequence corresponding with the
TTF-1 amino terminal protein in Ha-ras-FRTL-5 was obtained by
PCR using specific primers designed according to the previously pub-
lished TTF-1 sequence (27). Translation of the nucleotide sequence is
shown and demonstrates the lack of mutations affecting TTF-1 pri-
mary structure. The position of the previously identified phospho-
serines (15) and CNBr cleavage sites are indicated. B, Chromatog-
raphy of peptide CN-3, originated by chemical cleavage of peptides 3
(FRTL-5), 3a and 3b (Ha-ras-FRTL-5) with CNBr.
FIG. 6. PKA partially reestablishes TTF-1 activity in Ha-ras-FRTL-5
cells. Ten micrograms of the construct containing five TTF-1 binding
sites (5C-CAT) alone or in combination with 2 mg of a plasmid con-
taining either the catalytic subunit or the mutated PKA were tran-
siently cotransfected to Ha-ras-FRTL-5 cells. Same experimental ap-
proach was performed with the TATA-CAT promoterless construct.
CAT activity was normalized for transfection efficiency and expressed
as fold induction relative to the activity of 5C-CAT transfected alone
(value 1). The data are from three independent experiments.
2800 TTF-1 PHOSPHORYLATION IN Ha-ras TRANSFORMED CELLS Endo • 1998
Vol 139 • No 6
 by on May 10, 2010 endo.endojournals.orgDownloaded from 
sumably altered in Ha-ras-FRTL-5 cells, may be responsible
for the final phosphorylation stage of TTF-1.
Discussion
It is well established that TTF-1 plays an important role in
thyroid cellular processes such as differentiation, prolifera-
tion, and development (1, 13, 30–32), promoting the expres-
sion of specific thyroid genes. These genes are actively ex-
pressed in the differentiated cell line FRTL-5 under normal
conditions. Transformation of FRTL-5 cells by different on-
cogenes frequently leads to the loss of the thyroid specific
markers Tg and TPO, along with the absence of TTF-1 mRNA
(14). An exception to this mechanism is observed in the
Ha-ras-FRTL-5 cell line. These cells have lost the expression
of Tg and TPO, although they exhibit normal levels of TTF-1
protein (14), suggesting a subtle postranscriptional mecha-
nisms of regulation.
One of the most common mechanisms affecting transcrip-
tion factor activity is phosphorylation, so we focused our
attention in changes in orthophosphate incorporation into
TTF-1. Because this factor is inactive in Ha-ras transformed
FRTL-5 cells, we also explored whether the transcription
factor was able to bind its DNA recognition site and/or
whether its transcriptional activity was impaired. These two
possibilities, along with changes in the subcellular distribu-
tion, are the most common ways by which phosphorylation
alters the activity of a transcription factor (33, 34). The de-
tection of equal amount of TTF-1 protein in nuclear extracts
from both normal and transformed cells ruled out the latter
possibility. In addition, our results indicate that hypophos-
phorylated TTF-1 in Ha-ras-FRTL-5 cells is able to bind DNA,
although its ability to transactivate is lost. Modification of
phosphorylation upon oncogenic transformation of some
transcription factors have been described in other cell sys-
tems (35, 36). This modification normally affects DNA bind-
ing activity of the targeted transcription factor. Interesting
for our studies is the fact that ras affects phosphorylation of
c-jun transcriptional activation domain (37). Activation of
protein kinase C by ras transformation also decreases phos-
phorylation of c-jun at sites that inhibit its DNA binding
capacity (38). Due to the pleiotropic effect of ras, there is a
possibility that it could also modify TTF-1 transactivation
activity.
In a previous work, transfection in HeLa cells of TTF-1
mutant derivatives carrying Ser/Ala substitutions deter-
mined that phosphorylation is not involved in controlling
TTF-1/DNA binding (15). However, other studies indicate
that phosphorylation of this transcription factor is essential
for DNA binding in thyroid cells (16), suggesting that reg-
ulation of TTF-1 function is likely to be specific in the thyroid
context. Our results of phosphopeptide mapping of TTF-1 in
Ha-ras-FRTL-5 cells, along with a transfection approach with
mutant derivatives, indicate that the reduction of TTF-1
phosphorylation is accompanied by an heterogeneous pat-
tern of the phosphopeptides affecting the N-terminal domain
of the protein. The higher mobility of the spot 3b, only
present in Ha-ras transformed cells, indicates that this pep-
tide corresponds to a highly phosphorylated form of peptide
3a. We interpret these results considering that, although the
equilibrium between phosphorylated and nonphosphory-
lated forms of the TTF-1 protein is displaced to the latter
form, some population of highly phosphorylated TTF-1 mol-
ecules are present in those cells transformed by Ha-ras. This
observation may indicate that a precise equilibrium between
kinases and phosphatases responsible for TTF-1 phosphor-
ylation is necessary for the correct function of this transcrip-
tion factor.
The fact that the N-terminal stretch of the TTF-1 protein is
involved in phosphorylation alterations in Ha-ras-FRTL-5
cells may be of special interest because previous results have
designated this N-terminal region as one of the TTF-1 trans-
activation domain (17). In the N-terminal site of the TTF-1
protein, several consensus sequences for protein kinases
have been observed. The sites that we have identified by
computer analysis show homology to casein kinase II (CKII),
protein kinase C (PKC), and mitogen-actived protein kinase
(MAPK) (15), and we have previously demonstrated that
PKC is able to in vitro phosphorylate TTF-1 (15). A recent
report also localizes and functionally characterizes a PKA
phosphorylation site within this N-terminal motif of TTF-1 in
lung cells (29). Our results cotransfecting the catalytic sub-
unit of the PKA into Ha-ras-FRTL-5 cells show a moderate
increase in a reporter construct depending on TTF-1, sug-
gesting that although PKA may participate in the regulation
of TTF-1 phosphorylation, it is not sufficient to reestablish
basal levels of TTF-1 transcriptional activity in Ha-ras trans-
formed cells. Taken together, these observations indicate that
phosphorylation of TTF-1 at the N-terminal site is a rather
complex mechanism in which different kinases are involved.
We have to consider that Ha-ras induces cellular transfor-
mation by activating several signal transduction pathways
including the Raf-MEK-MAPK and the PKC cascades (28),
and also a modest reduction in PKA activity has been re-
ported in Ha-ras transformed FRTL-5 cells (39). How these
pathways integrate to precisely modulate TTF-1 function
remains to be elucidated.
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